Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Not yet recruiting 3Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 7INDUSTRY 4OTHER_GOV 2NIH 1

Study Type

Observational 4Interventional 3

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 2315Neoplasms 1678Prostatic Neoplasms 1178Lung Neoplasms 908Colorectal Neoplasms 873Carcinoma, Non-Small-Cell Lung 848Leukemia, Myeloid, Acute 587Pancreatic Neoplasms 568Multiple Myeloma 542Carcinoma, Hepatocellular 510Brain Neoplasms 509Neoplasm Metastasis 456Head and Neck Neoplasms 454Melanoma 410Ovarian Neoplasms 404Glioblastoma 397Precursor Cell Lymphoblastic Leukemia-Lymphoma 390Stomach Neoplasms 370Uterine Cervical Neoplasms 355Squamous Cell Carcinoma of Head and Neck 355Rectal Neoplasms 336Recurrence 332Hematologic Neoplasms 323Sarcoma 322Colonic Neoplasms 316Lymphoma 310Triple Negative Breast Neoplasms 284Urinary Bladder Neoplasms 279Glioma 277Carcinoma, Renal Cell 277

Interventions

Dexamethasone 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
OTHER × Hypersensitivity × 1 year × Clear all
NCT06279143 2026-05-26

dOCT-pBCC

Vejle Hospital

Completed
210 enrolled
Dermatologic

Carcinoma, Carcinoma, Basal Cell, Eyelid Diseases, Eyelid Neoplasms, Hypersensitivity, Neoplasms, Glandular and Epithelial, Recurrence, Skin Diseases, Skin Neoplasms

NCT07511517 2026-04-09

BladMetrix

Oslo University Hospital

Active not recruiting
500 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Hypersensitivity

NCT07478315 2026-03-17

IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life

Charles LeMoyne Hospital

Phase NA Not yet recruiting
50 enrolled
Breast

Breast Neoplasms, Hypersensitivity

NCT07420036 2026-03-03

SFB6-ZN01 PET

Zhongnan Hospital

Phase EARLY_PHASE1 Not yet recruiting
98 enrolled

Hypersensitivity, Neoplasms

NCT07209774 2025-10-07

Healthspan Connect Programme of Research

King's College London

Not yet recruiting
100,000 enrolled

Psychological Well-Being, Hypersensitivity, Neoplasms

NCT03598426 2025-09-03

Conventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel Hypersensitivity

Loma Linda University

Phase 3 Completed
90 enrolled

Hypersensitivity

NCT07010380 2025-06-18

PTFinder

Fujian Medical University

Recruiting
180 enrolled
Head & Neck

Hyperparathyroidism, Hypersensitivity, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡